TapewireFind a company

person · Reporting owner

Mino Robert P.

Disclosed activity across 1 company

Tapewire entity
133095
SEC CIK
0001804202

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
HealthLynked CorpHLYK · Entity 8075DirectorNovember 22, 2021November 24, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

HealthLynked Corp

Report date November 22, 2021 · Filed November 24, 2021 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect638,604 Reported balance After 2021-11-22 transaction · row 1 Amendment: may correct only part of an earlier disclosure.
1 source row

Row 1 · 2021-11-22 · Grant · Acquired 74,766 · Balance 638,604

F1: This amendment is being filed to correct the number of shares included in the grant and the date of grant previously reported on the original Form 4 that was filed with the U.S. Securities and Exchange Commission on November 16, 2021.

F2: Shares vest 25% on 12/31/2021, 25% on 3/31/2022, 25% on 6/30/2022 and 25% on 9/30/2022.

Filing footnotes · ownership attribution and instrument terms

F1: This amendment is being filed to correct the number of shares included in the grant and the date of grant previously reported on the original Form 4 that was filed with the U.S. Securities and Exchange Commission on November 16, 2021.

F2: Shares vest 25% on 12/31/2021, 25% on 3/31/2022, 25% on 6/30/2022 and 25% on 9/30/2022.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
November 22, 2021 Filed Nov 24, 2021 21:11 UTC Amendment HealthLynked Corp HLYK · Entity 8075 GrantCommon Stock 74,766 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-061950 · ownership.xml · nonDerivative · entry 1

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 638,604

F1 · date: This amendment is being filed to correct the number of shares included in the grant and the date of grant previously reported on the original Form 4 that was filed with the U.S. Securities and Exchange Commission on November 16, 2021.

F2 · shares: Shares vest 25% on 12/31/2021, 25% on 3/31/2022, 25% on 6/30/2022 and 25% on 9/30/2022.

Read SEC document
November 12, 2021 Filed Nov 16, 2021 21:14 UTC HealthLynked Corp HLYK · Entity 8075 GrantCommon Stock 68,942 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-060016 · ownership.xml · nonDerivative · entry 1

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 632,780

Read SEC document
April 30, 2021 Filed May 4, 2021 19:47 UTC HealthLynked Corp HLYK · Entity 8075 GrantCommon Stock 289,694 $0.00 $0.00
Disclosure

SEC source: 0001213900-21-024484 · ownership.xml · nonDerivative · entry 1

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,551

Read SEC document
March 02, 2021 Filed Mar 3, 2021 22:19 UTC HealthLynked Corp HLYK · Entity 8075 PurchaseWarrant (right to buy) · Derivative 25,000 $0.50 Strike: $0.60 $12,500.00
Disclosure

SEC source: 0001213900-21-013218 · ownership.xml · derivative · entry 2

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,429

Underlying: Common Stock · 25,000 shares

Expires 2026-03-01

F1 · price: Shares were purchased as 50,000 shares for $0.50 per share. Each unit consists of two shares of common stock and one warrant to purchase one warrant share of common stock at $0.60 per warrant share.

Read SEC document
March 02, 2021 Filed Mar 3, 2021 22:19 UTC HealthLynked Corp HLYK · Entity 8075 PurchaseCommon Stock 50,000 $0.50 $25,000.00
Disclosure

SEC source: 0001213900-21-013218 · ownership.xml · nonDerivative · entry 1

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,857

F1 · price: Shares were purchased as 50,000 shares for $0.50 per share. Each unit consists of two shares of common stock and one warrant to purchase one warrant share of common stock at $0.60 per warrant share.

Read SEC document
January 03, 2020 Filed Mar 3, 2020 21:13 UTC HealthLynked Corp HLYK · Entity 8075 GrantWarrant (right to buy) · Derivative 71,429 $0.09 Strike: $0.24 $6,214.32
Disclosure

SEC source: 0001213900-20-005282 · ownership.xml · derivative · entry 2

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,429

Underlying: Common Stock · 1,200,000 shares

Expires 2025-01-02

Read SEC document
January 03, 2020 Filed Mar 3, 2020 21:13 UTC HealthLynked Corp HLYK · Entity 8075 GrantCommon Stock 142,857 $0.14 $19,999.98
Disclosure

SEC source: 0001213900-20-005282 · ownership.xml · nonDerivative · entry 1

Mino Robert P. · CIK 0001804202 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,857

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.